Status:

ACTIVE_NOT_RECRUITING

Uncemented Tritanium TKR vs Cemented Triathlon TKR

Lead Sponsor:

Royal Devon and Exeter NHS Foundation Trust

Collaborating Sponsors:

University of Exeter

Conditions:

Knee Osteoarthritis

Eligibility:

All Genders

50-70 years

Phase:

NA

Brief Summary

The Study aims to investigate whether there is a clinically important difference in peri-articular bone mineral density (BMD) and trabecular bone score (TBS) between patients undergoing two different ...

Detailed Description

There have been many studies published that have shown a reduction in bone density around knee replacements. Exact reasons for this are not fully understood but one theory is that the stresses transmi...

Eligibility Criteria

Inclusion

  • Patients undergoing primary TKR at the RD+E Hospital
  • Patients must have completed a consent form for the study
  • Patients must be prepared to comply with the pre and post-operative investigations, attendance schedule and questionnaire schedule of the study
  • If the knee for surgery is suitable for standard condylar TKR components
  • The diagnosis is of tricompartmental osteoarthritis of the knee
  • Aged 50-70 years at time of surgery

Exclusion

  • Refusal to consent to the study
  • If the knee for surgery is not suitable for standard condylar TKR.
  • Pregnancy
  • Prisoners
  • A patient known to have substance abuse or psychological disorders that could interfere with their ability to comply with the assessment schedules
  • Patients unable to read or understand the patient information leaflet and consent form
  • Patients who have a Body Mass Index (BMI) ≥ 38
  • Patient has an active or suspected latent infection in or about the affected knee joint at time of study device implantation
  • Patient has received any orthopaedic surgical intervention to the lower extremities within the past year or is expected to require any orthopaedic surgical intervention to the lower extremities, other than the TKR to be enrolled in this study, within the next year
  • Patient requires bilateral total knee replacements, or has a history of unsuccessful contralateral partial or total knee replacement
  • Patient has a neuromuscular or neurosensory deficiency, which limits the ability to evaluate the safety and efficacy of the device
  • Patient is diagnosed with a systemic disease (e.g. Lupus Erythematosus) or a metabolic disorder (e.g. Paget's disease) leading to progressive bone deterioration
  • Patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements (e.g. \> 30 days)
  • Patients currently taking bisphosphonate medication or have taken within the previous 10 years
  • The presence of peri-articular cysts evident on the pre-operative x-ray such as could compromise the stability at the bone implant interface if the uncemented component is used
  • A past history of tibial or femoral osteotomy surgery

Key Trial Info

Start Date :

October 15 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2026

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04040764

Start Date

October 15 2019

End Date

June 1 2026

Last Update

February 12 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Royal Devon and Exeter NHS Foundation Trust Hospital

Exeter, Devon, United Kingdom, EX2 5DW